Clinical Trial

Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The treatment of generalized anxiety disorder (GAD) in an accessible manner represents an unmet need for those with cardiovascular disease (CVD), given that patients with CVD experience numerous barriers for in-person treatment engagement. The research plan for the proposed pilot project will entail: (1) open study of the acceptability of the digital intervention (N=5), followed by (2) recruitment and randomization of 90 individuals with a history of acute CVD events and clinical levels of GAD symptoms to dCBT or a waitlist (Control) condition, using a 1.5:1 allocation (dCBT:Control).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-05-17; most recent amendment 2025-03-13.
Status change: Not Yet Recruiting → Recruiting 2022-05-05
Trial Details
NCT Number NCT04895995
Lead Sponsor Boston University Charles River Campus
Conditions Anxiety Disorders, Cardiovascular Diseases, Anxiety, Health Behavior
Enrollment 95 participants
Start Date 2022-02-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-14